$51.8 Million is the total value of HealthInvest Partners AB's 53 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 470.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
UTMD | Buy | UTAH MED PRODS INC | $9,449,820 | +28.8% | 94,000 | +9.3% | 18.25% | +17.7% |
CAH | Buy | CARDINAL HEALTH INC | $7,687,000 | +64.7% | 100,000 | +42.9% | 14.84% | +50.5% |
CI | Sell | CIGNA CORP NEW | $5,301,440 | +12.4% | 16,000 | -5.9% | 10.24% | +2.7% |
VTRS | Sell | VIATRIS INC | $5,286,750 | +29.3% | 475,000 | -1.0% | 10.21% | +18.2% |
New | GSK PLCsponsored adr | $5,271,000 | – | 150,000 | +100.0% | 10.18% | – | |
GILD | Sell | GILEAD SCIENCES INC | $5,216,246 | -19.5% | 60,760 | -42.1% | 10.07% | -26.4% |
CVS | New | CVS HEALTH CORP | $4,845,880 | – | 52,000 | +100.0% | 9.36% | – |
BMY | Sell | BRISTOL-MYERS SQUIBB CO | $4,676,750 | -32.9% | 65,000 | -33.7% | 9.03% | -38.6% |
KMPH | Sell | KEMPHARM INC | $1,514,700 | -67.6% | 330,000 | -56.0% | 2.92% | -70.4% |
AUPH | AURINIA PHARMACEUTICALS INC | $993,600 | -42.6% | 230,000 | 0.0% | 1.92% | -47.5% | |
UNH | New | UNITEDHEALTH GROUP INC | $200,938 | – | 379 | +100.0% | 0.39% | – |
ABBV | New | ABBVIE INC | $131,066 | – | 811 | +100.0% | 0.25% | – |
MRK | New | MERCK & CO INC | $123,155 | – | 1,110 | +100.0% | 0.24% | – |
LLY | New | LILLY ELI & CO | $122,556 | – | 335 | +100.0% | 0.24% | – |
TMO | New | THERMO FISHER SCIENTIFIC INC | $121,152 | – | 220 | +100.0% | 0.23% | – |
REGN | New | REGENERON PHARMACEUTICALS | $67,099 | – | 93 | +100.0% | 0.13% | – |
PFE | New | PFIZER INC | $62,513 | – | 1,220 | +100.0% | 0.12% | – |
VRTX | New | VERTEX PHARMACEUTICALS INC | $62,376 | – | 216 | +100.0% | 0.12% | – |
ABC | New | AMERISOURCEBERGEN CORP | $51,204 | – | 309 | +100.0% | 0.10% | – |
BSX | New | BOSTON SCIENTIFIC CORP | $49,092 | – | 1,061 | +100.0% | 0.10% | – |
SYK | New | STRYKER CORPORATION | $48,409 | – | 198 | +100.0% | 0.09% | – |
IQV | New | IQVIA HLDGS INC | $44,051 | – | 215 | +100.0% | 0.08% | – |
BMRN | New | BIOMARIN PHARMACEUTICAL INC | $42,845 | – | 414 | +100.0% | 0.08% | – |
DXCM | New | DEXCOM INC | $33,859 | – | 299 | +100.0% | 0.06% | – |
MRNA | New | MODERNA INC | $33,589 | – | 187 | +100.0% | 0.06% | – |
RPRX | New | ROYALTY PHARMA PLC | $31,260 | – | 791 | +100.0% | 0.06% | – |
EW | New | EDWARDS LIFESCIENCES CORP | $26,561 | – | 356 | +100.0% | 0.05% | – |
NBIX | New | NEUROCRINE BIOSCIENCES INC | $22,216 | – | 186 | +100.0% | 0.04% | – |
MASI | New | MASIMO CORP | $22,488 | – | 152 | +100.0% | 0.04% | – |
OPCH | New | OPTION CARE HEALTH INC | $22,146 | – | 736 | +100.0% | 0.04% | – |
ALNY | New | ALNYLAM PHARMACEUTICALS INC | $22,101 | – | 93 | +100.0% | 0.04% | – |
CYTK | New | CYTOKINETICS INC | $20,161 | – | 440 | +100.0% | 0.04% | – |
ITCI | New | INTRA-CELLULAR THERAPIES INC | $15,453 | – | 292 | +100.0% | 0.03% | – |
DOCS | New | DOXIMITY INCcl a | $15,505 | – | 462 | +100.0% | 0.03% | – |
RXDX | New | PROMETHEUS BIOSCIENCES INC | $13,420 | – | 122 | +100.0% | 0.03% | – |
EXAS | New | EXACT SCIENCES CORP | $13,269 | – | 268 | +100.0% | 0.03% | – |
INSP | New | INSPIRE MED SYS INC | $13,098 | – | 52 | +100.0% | 0.02% | – |
KRYS | New | KRYSTAL BIOTECH INC | $11,012 | – | 139 | +100.0% | 0.02% | – |
AKRO | New | AKERO THERAPEUTICS INC | $9,097 | – | 166 | +100.0% | 0.02% | – |
BLU | New | BELLUS HEALTH INC NEW | $8,837 | – | 1,075 | +100.0% | 0.02% | – |
OM | New | OUTSET MED INC | $8,882 | – | 344 | +100.0% | 0.02% | – |
PRTA | New | PROTHENA CORP PLC | $7,893 | – | 131 | +100.0% | 0.02% | – |
MRVI | New | MARAVAI LIFESCIENCES HLDGS I | $6,797 | – | 475 | +100.0% | 0.01% | – |
BCYC | New | BICYCLE THERAPEUTICS PLCsponsored adr | $6,690 | – | 226 | +100.0% | 0.01% | – |
SWAV | New | SHOCKWAVE MED INC | $6,580 | – | 32 | +100.0% | 0.01% | – |
FOLD | New | AMICUS THERAPEUTICS INC | $6,764 | – | 554 | +100.0% | 0.01% | – |
KRTX | New | KARUNA THERAPEUTICS INC | $6,681 | – | 34 | +100.0% | 0.01% | – |
BBIO | New | BRIDGEBIO PHARMA INC | $6,759 | – | 887 | +100.0% | 0.01% | – |
IMGN | New | IMUNOGEN INC | $6,448 | – | 1,300 | +100.0% | 0.01% | – |
PSTX | New | POSEIDA THERAPEUTICS INC | $5,666 | – | 1,069 | +100.0% | 0.01% | – |
MRUS | New | MERUS N V | $4,424 | – | 286 | +100.0% | 0.01% | – |
New | ARCELLX INC | $4,399 | – | 142 | +100.0% | 0.01% | – | |
DNLI | New | DENALI THERAPEUTICS INC | $4,394 | – | 158 | +100.0% | 0.01% | – |
OPNT | Exit | OPIANT PHARMACEUTICALS INC | $0 | – | -210,000 | -100.0% | -4.77% | – |
MCK | Exit | MCKESSON CORP | $0 | – | -13,000 | -100.0% | -9.33% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
CHARLES RIV LABS INTL INC | 17 | Q4 2017 | 12.8% |
GILEAD SCIENCES INC | 16 | Q4 2022 | 14.5% |
CARDINAL HEALTH INC | 15 | Q4 2022 | 14.8% |
IMMUCELL CORP | 15 | Q2 2017 | 1.7% |
MCKESSON CORP | 14 | Q3 2022 | 14.6% |
ANTHEM INC | 12 | Q4 2017 | 14.3% |
TRIPLE-S MGMT CORP | 12 | Q4 2016 | 8.7% |
LIFEPOINT HOSPITALS INC | 11 | Q2 2016 | 13.3% |
SUPERNUS PHARMACEUTICALS INC | 10 | Q3 2021 | 15.5% |
ANIKA THERAPEUTICS INC | 10 | Q4 2017 | 13.0% |
View HealthInvest Partners AB's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
NOVAMED INC | March 03, 2011 | 405,875 | 5.1% |
THERAGENICS CORP | February 11, 2009 | 3,322,846 | 9.9% |
BIO IMAGING TECHNOLOGIES INC | January 09, 2009 | 766,425 | 5.3% |
ALLION HEALTHCARE INC | July 07, 2008 | 887,255 | 4.6% |
SONIC INNOVATIONS INC | June 26, 2008 | 1,328,201 | 4.9% |
CANDELA CORP /DE/ | June 06, 2008 | 697,164 | 3.1% |
INTEGRAMED AMERICA INC | June 02, 2008 | 2,200 | 0.0% |
AFP IMAGING CORP | February 04, 2008 | 27,520 | 0.2% |
OPHTHALMIC IMAGING SYSTEMS | December 28, 2007 | 834,440 | 4.9% |
ANGEION CORP/MN | October 16, 2007 | 196,024 | 4.8% |
View HealthInvest Partners AB's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-04-25 |
13F-HR | 2024-01-30 |
13F-HR | 2023-02-14 |
13F-HR | 2022-10-21 |
13F-HR | 2022-07-08 |
13F-HR | 2022-05-05 |
13F-HR | 2022-01-18 |
13F-HR | 2021-11-08 |
13F-HR | 2021-08-10 |
13F-HR | 2021-04-30 |
View HealthInvest Partners AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.